Arbor Biotechnologies
Adele Bubnys is a Senior Scientist at Arbor Biotechnologies, with experience in developing gene editing therapies for neurological disorders. Previously, Adele worked at The Picower Institute for Learning and Memory as a Postdoctoral Researcher focusing on neurodegeneration mechanisms in APOE4 carriers. Prior to that, Adele was a Graduate Fellow at the Laboratory of Neurobiology and Behavior, where Adele studied the role of generalized arousal in mammalian motor activity for their doctoral dissertation. Adele holds a PhD in Biomedical Sciences from The Rockefeller University and a BA in Biochemistry and Molecular Biology from Wesleyan University.
Arbor Biotechnologies
2 followers
Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the discovery of proteins for improving human health and sustainability.